Drug Profile
Chlorogenic acid - Sichuan J.Z. Bio-chemical Science and Technology Development
Alternative Names: 3-caffeoylquinic-acid ; 3-O-caffeoylquinic-acid ; Coffee tannic acid; Hlorogenic-acidLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Sichuan J.Z. Bio-chemical Science and Technology Development Co
- Class Antineoplastics; Cinnamates; Cyclohexanecarboxylic acids; Esters; Small molecules
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II/III Glioblastoma
- Phase I/II Non-small cell lung cancer; Small cell lung cancer
- No development reported Cancer
Most Recent Events
- 05 Mar 2021 Chlorogenic acid is still in Phase-II/III clinical trials in Glioblastoma in China (Parenteral)
- 05 Mar 2021 Chlorogenic is still in Phase-I/II clinical trials in Small cell lung cancer and Non-small cell lung cancer in China (IM)
- 10 Dec 2018 Phase-II/III clinical trials in Glioblastoma (Late-stage disease, Second-line therapy or greater) in China (Parenteral) (NCT03758014)